Chemoinformaics analysis of Retusin-8-O-Alpha-L-Arabinopyranoside
| Molecular Weight | 416.382 | nRot | 4 |
| Heavy Atom Molecular Weight | 396.222 | nRig | 24 |
| Exact Molecular Weight | 416.111 | nRing | 4 |
| Solubility: LogS | -4.169 | nHRing | 2 |
| Solubility: LogP | 1.126 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 55.6239 |
| nHD | 4 | BPOL | 27.8761 |
| QED | 0.49 |
| Synth | 3.68 |
| Natural Product Likeliness | 1.444 |
| NR-PPAR-gamma | 0.731 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.304 |
| HIA | 0.253 |
| CACO-2 | -5.858 |
| MDCK | 0.0000116 |
| BBB | 0.295 |
| PPB | 0.845579 |
| VDSS | 0.761 |
| FU | 0.114311 |
| CYP1A2-inh | 0.073 |
| CYP1A2-sub | 0.126 |
| CYP2c19-inh | 0.072 |
| CYP2c19-sub | 0.073 |
| CYP2c9-inh | 0.068 |
| CYP2c9-sub | 0.674 |
| CYP2d6-inh | 0.233 |
| CYP2d6-sub | 0.572 |
| CYP3a4-inh | 0.143 |
| CYP3a4-sub | 0.069 |
| CL | 3.616 |
| T12 | 0.339 |
| hERG | 0.058 |
| Ames | 0.286 |
| ROA | 0.095 |
| SkinSen | 0.118 |
| Carcinogencity | 0.831 |
| EI | 0.017 |
| Respiratory | 0.047 |
| NR-Aromatase | 0.884 |
| Antiviral | Yes |
| Prediction | 0.919124 |